Saira Khan, PhD, MPH

Primary Academic Title

Assistant Professor of Surgery, Division of Public Health Sciences, Washington University School of Medicine

Research Interest

Prostate cancer outcomes and disparities, with a particular focus on cardiovascular risk factors including diabetes, obesity and weight gain, as well as related medications including metformin and statins.

Education

2008: MPH, epidemiology, Drexel University, Philadelphia
2016: PhD, epidemiology, University of North Carolina, Chapel Hill

Training

2016 - 2019: Postdoctoral research scholar, cancer prevention and control, Washington University, St. Louis

Selected Research Publications

The impact of marital status on tumor aggressiveness, treatment, and screening among black and white men diagnosed with prostate cancer.

Khan S, Fuzzell L, Langston M, [...] Lewis-Thames MW
Cancer Causes Control 2024

Local Treatment and Treatment-Related Adverse Effects Among Patients With Advanced Prostate Cancer.

Khan S, Chang SH, Wang M, [...] Drake BF
JAMA Netw Open 2023

Post-diagnostic metformin and statin use and risk of biochemical recurrence in Veterans diagnosed with prostate cancer.

Khan S, Chang SH, Seyerle AA, [...] Drake BF
Prostate 2023

Using health insurance claims data to assess long-term disease progression in a prostate cancer cohort.

Khan S, Vohra S, Farnan L, [...] Bensen JT
Prostate 2022

Racial and Ethnic Differences in Rural-Urban Trends in 5-Year Survival of Patients With Lung, Prostate, Breast, and Colorectal Cancers: 1975-2011 Surveillance, Epidemiology, and End Results (SEER).

Lewis-Thames MW, Langston ME, Khan S, [...] Moore JX
JAMA Netw Open 2022

Improved survival with post-diagnostic metformin and statin use in a racially diverse cohort of US Veterans with advanced prostate cancer.

Khan S, Chang SH, Hicks V, [...] Drake BF
Prostate Cancer Prostatic Dis 2022

View All Publications

Siteman Cancer Center ranked No. 10 among U.S. cancer centers

Diversity, Equity & Inclusion at Siteman

How Siteman is leading the way in personalized brain tumor treatment

Siteman Cancer Center expands proton therapy treatment

Siteman explains what every woman should know about endometrial cancer risk, symptoms and screening

Immunity boosting treatment enhances CAR-T cell therapy for blood cancers

$5.3 million grant supports research into lung cancer recurrence

Couple honors physician with gift for distinguished professorship

Siteman Cancer Center ranked No. 10 among U.S. cancer centers

Siteman Cancer Center ranked No. 10 among U.S. cancer centers

Diversity, Equity & Inclusion at Siteman

How Siteman is leading the way in personalized brain tumor treatment

Treatment
Clinical
How Siteman is leading the way in personalized brain tumor treatment
If you or a loved one have recently been diagnosed with a brain tumor, you likely feel a great deal of fear and have many questions. The brain is the epicenter of who we are,...
Read The Full Story

How Siteman is leading the way in personalized brain tumor treatment

Cancer Types

The Siteman Approach

Specialized Programs

Siteman Cancer Center expands proton therapy treatment

Siteman Cancer Center expands proton therapy treatment

Siteman explains what every woman should know about endometrial cancer risk, symptoms and screening

Siteman explains what every woman should know about endometrial cancer risk, symptoms and screening

Immunity boosting treatment enhances CAR-T cell therapy for blood cancers

Immunity boosting treatment enhances CAR-T cell therapy for blood cancers

$5.3 million grant supports research into lung cancer recurrence

$5.3 million grant supports research into lung cancer recurrence

Couple honors physician with gift for distinguished professorship

Couple honors physician with gift for distinguished professorship

Saira Khan, PhD, MPH

Primary Academic Title

Research Interest

Education

Training

Selected Research Publications